Ocular tension and pupil diameter effects of timolol 0.50% and pilocarpine 2% or 4% in association.
Taverniti
L
L
Eye Clinic, University La Sapienza of Rome.
Voccia
L
L
Amoroso
L
L
De Stefano
C
C
Virno
M
M
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage*; D000368:Aged; D002908:Chronic Disease; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D005902:Glaucoma, Open-Angle / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects*; D008297:Male; D008875:Middle Aged; D008916:Miotics / Q000008:administration & dosage*; D009798:Ocular Hypertension / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology; D009883:Ophthalmic Solutions; D010862:Pilocarpine / Q000008:administration & dosage*; D011680:Pupil / Q000187:drug effects*; D013999:Timolol / Q000008:administration & dosage*; D016896:Treatment Outcome
D000319:Adrenergic beta-Antagonists; D008916:Miotics; D009883:Ophthalmic Solutions; D010862:Pilocarpine; D013999:Timolol